ロード中...
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Advanced hepatocellular carcinoma has limited treatment options, but there has been extensive growth recently with cabozantinib, regorafenib, lenvatinib, nivolumab, atezolizumab, and bevacizumab, which are some of the treatments that have received FDA approval just over the last three years. Because...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2020-08-01
|
| シリーズ: | Vaccines |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/2076-393X/8/3/447 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|